Physician Wealth Advisors’s MBX Biosciences MBX Stock Holding History

Physician Wealth Advisors’s Portfolio MBX Stock Details MBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.68K	Buy	121 +12	+11%	+$419	﹤0.01%	992
2026 Q1	$3.25K	Hold	109	–	–	﹤0.01%	1147
2025 Q4	$3.44K	Hold	109	–	–	﹤0.01%	1089
2025 Q3	$1.91K	Hold	109	–	–	﹤0.01%	1250
2025 Q2	$1.24K	Buy	+109	New	+$1.11K	﹤0.01%	1253

Other funds holding MBX

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

KWM

Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SIC

SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Physician Wealth Advisors's MBX Position: Q2 2026 in Review

Physician Wealth Advisors increased its MBX Biosciences (MBX) stake by 11% in Q2 2026, buying an estimated $419 and bringing the position to 121 shares worth $6.68K. The position accounts for ﹤0.01% of the portfolio, ranked #992.

Physician Wealth Advisors first reported a position in MBX in Q2 2025 and has held it in 5 quarters since. 12 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

Physician Wealth Advisors held 121 shares of MBX Biosciences worth $6.68K as of Q2 2026.
Physician Wealth Advisors bought 12 MBX Biosciences shares in Q2 2026, an estimated $419.
MBX Biosciences made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #992 holding.
Physician Wealth Advisors first reported a position in MBX Biosciences in Q2 2025 and has held it in 5 quarters since.
12 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.